Omeros | OMER - Umlaufvermögen

Aktienkurs
11.00
Täglich Wechseln
-0.12 -1.08%
Monatlich
-3.85%
Jährlich
20.88%
Q1 Prognose
10.67




Umlaufvermögen Veränderung Datum
Adma Biologics USD 466.51M 63.86M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Immunic USD 39.27M 20.57M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Rockwell Medical USD 31.61M 1.42M 2025-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09